Moleen Zunza
Stellenbosch University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Moleen Zunza.
Journal of the International AIDS Society | 2013
Moleen Zunza; Gareth Mercer; Lehana Thabane; Monika Esser; Mark F. Cotton
Guidelines in resource‐poor settings have progressively included interventions to reduce postnatal HIV transmission through breast milk. In addition to HIV‐free survival, infant growth and non‐HIV infections should be considered. Determining the effect of these interventions on infant growth and non‐HIV infections will inform healthcare decisions about feeding HIV‐exposed infants. We synthesize findings from studies comparing breast to formula feeding, early weaning to standard‐duration breastfeeding, breastfeeding with extended antiretroviral (ARV) to short‐course ARV prophylaxis, and alternative preparations of infant formula to standard formula in HIV‐exposed infants, focusing on infant growth and non‐HIV infectious morbidity outcomes. The review objectives were to collate and appraise evidence of interventions to reduce postnatal vertical HIV transmission, and to estimate their effect on growth and non‐HIV infections from birth to two years of age among HIV‐exposed infants.
Aids and Behavior | 2018
Moleen Zunza; Monika Esser; Amy L. Slogrove; Julie A. Bettinger; Rhoderick Machekano; Mark F. Cotton
As part of the Mother-Infant Health Study, we describe infant feeding practices among HIV-infected and HIV-uninfected mothers over a 12-month period when the Western Cape Province prevention of mother-to-child transmission (PMTCT) program was transitioning from a policy of exclusive formula feeding to one of exclusive breastfeeding. Two hundred pairs of mother and HIV-uninfected infant were included in the analysis, among whom 81 women were HIV uninfected and breastfeeding. Of the 119 HIV-infected mothers, 50 (42%) were breastfeeding and 69 (58%) were formula feeding. HIV-infected mothers predominantly breastfed for 8.14 (7.71–15.86) weeks; HIV-uninfected mothers predominantly breastfed for 8.29 (8.0–16.0) weeks; and HIV-infected mothers predominantly formula fed for 50.29 (36.43–51.43) weeks. A woman’s HIV status had no influence on the time to stopping predominant breastfeeding (P = 0.20). Our findings suggest suboptimal duration of breastfeeding among both HIV-infected and HIV-uninfected mothers. Providing support for all mothers postdelivery, regardless of their HIV status, may improve breastfeeding practices.
Contemporary clinical trials communications | 2017
Godsent Isiguzo; Moleen Zunza; Maxwell Chirehwa; Bongani M. Mayosi; Lehana Thabane
Introduction Pilot trials are initial small-scale studies done to inform the design of larger trials. Their findings like other studies are usually disseminated as peer-reviewed journal articles. Abstracts are used to introduce the contents to readers, and give a general idea about the full reports and sometimes are the only source of information available to readers. Despite their importance, the contents of abstracts of trial reports are usually not informative enough and lack the essential details. Methods and analysis This is a protocol for a planned systematic survey with a primary aim of analyzing the reporting quality measured as the completeness of the reporting of pilot trial abstracts in heart failure. The secondary aim will be to explore factors associated with better reporting quality. Abstracts of heart failure pilot trials in humans (journal and conference abstracts) published in the English language from 1 January 1990 to 30 November 2016 will be assessed to determine the reporting quality, based on the CONSORT 2010 statement extension to randomized pilot and feasibility trials. All non-pilot/feasibility trials and non-human pilot trials will be excluded. We will search Medline (PUBMED), Cochrane controlled trials register, Scopus and African wide information databases for pilot trials in heart failure. Title and abstracts of identified studies will be screened for inclusion and data extracted independently by two reviewers in duplicate without using the full text. Reported and unreported items on the abstracts will be presented as frequencies and percentages, a descriptive analysis will be used to interpret the reporting quality and regression analysis used for characteristics associated with greater statistical reporting at 95% confidence interval. Review registration number PROSPERO CRD42016049911.
IVF Lite | 2016
Thabo Matsaseng; Thinus F. Kruger; Moleen Zunza
Objective: To determine whether the use of prolonged, 8 days course of clomiphene citrate (CC) versus the standard use of 5 days is an effective method to prevent premature luteinizing hormone (LH) surge in assisted reproductive technology (ART) program. Materials and Methods: Eligible participants were randomized into one of the two treatment groups, In Group A, the patients received CC 100 mg for 5 days from cycle day 3-7 plus human menopausal gonadotropin (hMG), 150-225 IU on alternate days. In Group B, patients received CC 100 mg for 8 days from cycle day 3-10 plus hMG. Cycles were monitored with ultrasound and urinary LH tests only. Results: Two hundred and thirty-eight patients were randomized, but a total of 227 were analyzed. The percentage risk of premature LH surge was similar in both groups with (20% Group A vs. 24% Group B, P = 0.6) and there was no significant difference in live birth and clinical pregnancy rates per initiated cycle between the two groups, 6.4% Group A versus 10.6% in Group B and 12% (a) versus 17% (b), respectively. Cycle cancellation rates were also similar between the two groups, 36% (a) versus 31% (b). Conclusion: The trial shows that prolonged, 8 days course of CC does not suppress premature LH surge in ART program.
World Journal of Urology | 2018
Elias Pretorius; A. Zarrabi; Stephanie Griffith-Richards; Justin Harvey; Hilgard Ackermann; Catharina M. Meintjes; Willem G. Cilliers; Moleen Zunza; Alexander J. Szpytko; Richard Pitcher
IntroductionAlthough many radiologists invoke the surgical classification of renal injury proposed by the American Association for Surgery in Trauma (AAST), there has been only limited work on the role of the AAST system as an imaging stratification. The aim was to determine the inter-rater reliability (IRR) amongst radiologists and urologists using the AAST system.MethodsA 1-year retrospective study of consecutive patients with computed tomography (CT) evidence of renal trauma managed at a Level 1 trauma center. Three radiologists and three urologists independently stratified the presentation CT findings according to the AAST renal trauma classification. Agreement between independent raters and mutually exclusive groups was determined utilizing weighted kappa coefficients.ResultsOne hundred and one patients were included. Individual inter-observer agreements ranged from 54/101 (53.4%) to 62/101 (61.4%), with corresponding weighted kappa values from 0.61 to 0.69, constituting substantial agreement. Urologists achieved intra-disciplinary agreement in 49 cases (48.5%) and radiologists in 36 cases (35.6%). Six-reader agreement was achieved in 24 cases (23.7%). The AAST grade I injuries had the highest level of agreement, overall.ConclusionThe finding of substantial IRR amongst radiologists and urologists utilizing the AAST system supports continued use of the broad parameters of the AAST system, with some modification in specific categories with lower agreement.
Pilot and Feasibility Studies | 2018
Godsent Isiguzo; Moleen Zunza; Maxwell T. Chirehwa; Bongani M. Mayosi; Lehana Thabane
BackgroundPilot trials are miniature researches carried out with the sole aim of acting as the precursor for larger more definitive studies. Abstracts are used to summarize and introduce the findings to the reading audience. There is substantive empirical evidence showing that abstracts, despite their important roles, are not informative enough, lacking the necessary details. This systematic survey was designed to assess the quality of reporting of heart failure pilot trial abstracts. The quality of reporting was defined as the completeness of reporting based on adherence to the CONSORT extension for reporting of pilot trial abstracts. We also identified factors associated with reporting quality.MethodsWe searched MEDLINE (PubMed), Cochrane Controlled Trials Register, Scopus, and African-wide information databases for abstracts from heart failure pilot trials in humans published from 1 January 1990 to 30 November 2016. These were assessed to determine the extent of adherence to CONSORT extension checklist for reporting of abstracts of pilot trials. We screened identified studies for inclusion based on title and abstract. Data were independently extracted by two reviewers using the checklist. We used regression analysis to assess the association between completeness of reporting (measured as the number of items in the CONSORT extension checklist for reporting of abstracts in pilot trials contained in each abstract) and factors influencing the quality of the reports.ResultsTwo hundred and twenty-eight (228) articles were retrieved, of which 92 met the inclusion criteria. The mean CONSORT extension score was 8.3/16 (standard deviation 1.7); the least reported items were the source of funding (1% [1/92]), trial registration (13% [12/92]), randomization sequence (13% [12/92]), number randomized to each arm (16% [15/92]), and number analyzed in each arm (16% [15/92]). Multivariable regression analysis showed that pharmacological intervention pilot trials [incidence rate ratio (IRR) = 0.88; 95% confidence interval (CI), 0.81–0.97] were significantly associated with better reporting. Other factors such as structured abstract (IRR = 1.10; 95% CI, 0.99–1.23) and CONSORT endorsement (IRR = 1.10; 95% CI, 0.99–1.23) only showed minimal relationship with better reporting quality.ConclusionThe quality of reporting of abstracts of heart failure pilot trials was suboptimal. Pharmacological intervention was significantly associated with better reporting. These findings are consistent with previous research on reporting of trials.
HIV/AIDS : Research and Palliative Care | 2018
Lawrence Mbuagbaw; Amy L. Slogrove; Jacqueline Sas; John Lengwe Kunda; Frederick Morfaw; Jackson K Mukonzo; Wei Cao; Gisele Ngomba-Kadima; Moleen Zunza; Pierre Ongolo-Zogo; Philip N Nana; Anne Cockcroft; Neil Andersson; Nelson Sewankambo; Mark F. Cotton; Taishen Li; Taryn Young; Joel Singer; Jean-Pierre Routy; Colin Ross; Kyaw Thin; Lehana Thabane; Aslam H. Anis
As a response to the human immunodeficiency virus (HIV) epidemic and part of Canadian Institutes for Health Research’s mandate to support international health research capacity building, the Canadian Institutes for Health Research Canadian HIV Trial Network (CTN) developed an international postdoctoral fellowship award under the CTN’s Postdoctoral Fellowship Awards Program to support and train young HIV researchers in resource-limited settings. Since 2010, the fellowship has been awarded to eight fellows in Cameroon, China, Lesotho, South Africa, Uganda and Zambia. These fellows have conducted research on a wide variety of topics and have built a strong network of collaboration and scientific productivity, with 40 peer-reviewed publications produced by six fellows during their fellowships. They delivered two workshops at international conferences and have continued to secure funding for their research, using the fellowship as a stepping stone. The CTN has been successful in building local HIV research capacity and forming a strong network of like-minded junior low- and middle-income country researchers with high levels of research productivity. They have developed into mentors, supervisors and faculty members, who, in turn, build local capacity. The sustainability of this international fellowship award relies on the recognition of its strengths and the involvement of other stakeholders for additional resources.
African Journal of Primary Health Care & Family Medicine | 2018
Rekai L. Chinhoyi; Moleen Zunza; Klaus B. von Pressentin
Background A revised family physician (FP) training programme was introduced in South Africa in 2007. A baseline assessment (2011) of the impact of FP supply on district health system performance was performed within the Western Cape Province, South Africa. The impact of an increased FP supply within this province required re-evaluation. Aim To assess the impact of FP supply on indicators of district health system performance, clinical processes and clinical outcomes in the Western Cape Province. The objectives were to determine the impact of FPs, nurses, medical officers (MOs) and other specialists. Setting The study sample included all five rural districts and eight urban subdistricts of the Western Cape Province. Methods A secondary analysis was performed on routinely collected data from the Western Cape Department of Health from 01 March 2011 until 30 April 2014. Results The FP supply did not significantly impact the indicators analysed. The supply of nurses and MOs had an impact on some of the indicators analysed. Conclusion This study did not replicate the positive associations between an increase in FP supply and improved health indicators, as described previously for high-income country settings. The impact of FP supply on clinical processes, health system performance and outcome indicators in the Western Cape Province was not statistically significant. Future re-evaluation is recommended to allow for more time and an increase in FP supply.
Cochrane Database of Systematic Reviews | 2013
Adel Ferreira; Taryn Young; Catherine Mathews; Moleen Zunza; Nicola Low
Trials | 2017
Moleen Zunza; Mark F. Cotton; Lawrence Mbuagbaw; Richard Lester; Lehana Thabane